AbbVie reported that its JAK inhibitor Rinvoq showed superior efficacy to its TNF inhibitor Humira in rheumatoid arthritis ...
Mounjaro generated $8.7 billion for Lilly in the first quarter of 2026, outperforming Merck's Keytruda, which posted sales of ...
Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro has surpassed Merck & Co.’s cancer therapy Keytruda as the world’s ...
Rebates aren’t disappearing, but PSG's 2026 survey suggests payers increasingly favor lower net costs, biosimilars and price ...
CFO Matthew Korenberg said, “Palvella ended Q1 with $261.9 million in cash and cash equivalents,” and tied runway confidence to the “oversubscribed $230 million equity offering,” adding the company ...
Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) ...
With no known cure for focal segmental glomerulosclerosis (FSGS), many affected patients opt for kidney transplant. But even ...
Brepocitinib's expanding immunology franchise, Moderna LNP settlement, buybacks, and premium valuation risks. Read the full ...
The "direct-to" channel was a hot topic at the Asembia specialty pharmacy meeting this week in Las Vegas. The drug supply ...
Minnesota's Legislature is reckoning with 340B, a prescription medication discount program for nonprofit hospitals, for ...
Samsung Bioepis Co., Ltd. today released its Second Quarter 2026 Biosimilar Market Report, marking the thirteenth edition of the Quarterly Biosimilar Market Report in the United States (US). The ...
Johnson & Johnson will begin marketing four prescription drugs on the Trump administration’s TrumpRx website, according to an April 24 report from CBS News. The drugs include metformin, metformin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results